Accelerated approval brings BIO members’ breakthrough cancer treatments to patients facing unmet need—here are three recent examples. Plus, a Purdue University official explains why a plan to use Bayh-Dole to control prices will harm innovation. (627 words, 3 minutes, 8 seconds)

A House subcommittee advanced a bill to reauthorize the Rare Pediatric Priority Review Voucher (PPRV)—and the story of two young siblings fighting muscular dystrophy explains why. Also: BIO recently urged the Supreme Court to take a case that could have an impact on patents. (626 words, 3 minutes, 7 seconds)

It’s National Women’s Health Week, and we have a question: why is women’s health woefully underfunded? Meanwhile, Canada joins the U.S. in sensible regulation of gene-edited animal feed—leaving Mexico as the North American outlier. (597 words, 2 minutes, 59 seconds)